Daihan Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	154,938	171,990	154,056	163,170	183,600	172,200
Market Cap Growth	-2.59%	11.64%	-5.59%	-11.13%	6.62%	-12.90%
Enterprise Value	56,326	85,789	80,167	60,093	96,028	117,564
Last Close Price	26350.00	29250.00	25333.88	25919.62	27814.69	25531.67
PE Ratio	5.74	6.22	4.56	5.74	7.36	7.60
PS Ratio	0.73	0.82	0.75	0.83	1.00	1.00
PB Ratio	0.51	0.57	0.56	0.66	0.82	0.85
P/TBV Ratio	0.52	0.57	0.56	0.66	0.82	0.85
P/FCF Ratio	49.59	357.17	7.76	9.28	9.01	5.99
P/OCF Ratio	5.94	6.72	4.32	4.20	6.33	4.24
EV/Sales Ratio	0.27	0.41	0.39	0.31	0.52	0.69
EV/EBITDA Ratio	1.40	2.12	1.77	1.35	2.28	2.90
EV/EBIT Ratio	1.89	2.75	2.11	1.68	2.91	4.04
EV/FCF Ratio	18.03	178.16	4.04	3.42	4.71	4.09
Debt / Equity Ratio	0	0	0	-	0.03	0.12
Debt / EBITDA Ratio	0.00	0.00	0.00	-	0.15	0.58
Debt / FCF Ratio	0.02	0.03	0.00	-	0.32	0.82
Net Debt / Equity Ratio	-0.33	-0.30	-0.28	-0.42	-0.40	-0.36
Net Debt / EBITDA Ratio	-2.45	-2.22	-1.70	-2.35	-2.16	-1.80
Net Debt / FCF Ratio	-31.56	-185.91	-3.89	-5.94	-4.47	-2.53
Asset Turnover	0.62	0.62	0.66	0.69	0.67	0.65
Inventory Turnover	4.57	4.75	5.36	5.38	5.46	5.22
Quick Ratio	2.80	2.84	2.58	3.28	3.04	2.72
Current Ratio	3.61	3.64	3.22	3.87	3.65	3.20
Return on Equity (ROE)	9.31%	9.59%	12.89%	12.01%	11.66%	11.79%
Return on Assets (ROA)	5.45%	5.80%	7.69%	7.83%	7.50%	6.91%
Return on Invested Capital (ROIC)	12.11%	12.70%	17.74%	19.93%	18.62%	15.86%
Return on Capital Employed (ROCE)	9.70%	10.30%	13.50%	14.20%	14.10%	12.80%
Earnings Yield	17.41%	16.07%	21.91%	17.42%	13.59%	13.16%
FCF Yield	2.02%	0.28%	12.88%	10.77%	11.10%	16.71%
Payout Ratio	19.26%	18.79%	12.82%	13.20%	8.45%	9.30%
Buyback Yield / Dilution	-	-	-	1.75%	0.25%	-